Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Lubiprostone

Lubiprostone

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Lubiprostone

32 trials tracked of Lubiprostone: 25 in phase 3 or 4.

32Trials tracked
25Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 9 Phase 3 16 Phase 2 1 Phase 1 1 Other / NA 5
  1. Phase 4 Amitiza® Plus GoLYTELY® (PEG) Versus Placebo Plus GoLYTELY® for Outpatient Colonoscopy Preparation Completed
  2. Phase 4 Lubiprostone in Patients With Multiple Sclerosis Associated Constipation Completed
  3. Phase 4 Effects of Lubiprostone on Gastric Function in Patients With Chronic Idiopathic Constipation Completed
  4. Phase 4 Amitiza in Constipation Associated With PD (Parkinson's Disease) Completed
  5. Phase 4 Lubiprostone, Colonic Motility and Sensation Completed
  6. Phase 4 Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy Completed
Show 26 more trials
  1. Phase 4 The Effectiveness of Lubiprostone in Constipated Diabetics Completed
  2. Phase 4 Safety and Efficacy of Lubiprostone in Pediatric Patients With Constipation Completed
  3. Phase 4 Effects of Lubiprostone on Small Bowel and Colonic Bacteria: A Correlation Study With Segmental and Whole Gut Transit Completed
  4. Phase 3 Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation Completed
  5. Phase 3 Lubiprostone Effect on Gastrointestinal Tract Transit Times Measured by Smartpill in Patients With Chronic Constipation Completed
  6. Phase 3 Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone Completed
  7. Phase 3 Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation Completed
  8. Phase 3 Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone Completed
  9. Phase 3 Lubiprostone for Children With Constipation Completed
  10. Phase 3 Lubiprostone for Treatment of Chronic Idiopathic Constipation Completed
  11. Phase 3 Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL) Completed
  12. Phase 3 Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation Completed
  13. Phase 3 Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional Constipation Completed
  14. Phase 3 Lubiprostone in Children With Functional Constipation Completed
  15. Phase 3 Lubiprostone for Chronic Idiopathic Constipation Treatment Completed
  16. Phase 3 Lubiprostone and Mucus Secretion in Patients With Chronic Constipation Completed
  17. Phase 3 A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults Completed
  18. Phase 3 Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo Completed
  19. Phase 3 Lubiprostone for the Treatment of Chronic Idiopathic Constipation Completed
  20. Phase 2 Lubiprostone as a Modulator of Gut Microbial Translocation in HIV With Incomplete CD4 Recovery on Antiretroviral Therapy Completed
  21. Phase 1 Effect of Lubiprostone on Methanogenesis and Bowel Function in Chronic Constipation. Completed
  22. N/A Effects of Lubiprostone on Gastrointestinal Transit & pH in Irritable Bowel Syndrome (IBS) With Constipation Completed
  23. N/A Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-induced Constipation After Surgery in Inpatient Rehabilitation Completed
  24. N/A Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS) Completed
  25. N/A Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy Completed
  26. N/A Short Term Safety and Efficacy of Lubiprostone in Adults With Cystic Fibrosis Completed

Showing the 32 most-cited and recently-updated of 32 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.